Focus on Finasteride: Efficacy, Mechanisms, and Recommendations for Clinical Use

    March 2026 in “ Gazzetta Medica Italiana Archivio per le Scienze Mediche ”
    Luca Boeri
    Studysummary This analysis concluded that finasteride effectively reduces prostate size and urinary symptoms in benign prostatic hyperplasia, offering a favorable safety profile and versatility as a treatment option.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on minervamedica.it →
    Discuss this study in the Community →

    Research cited in this study 8

    1. Lower Urinary Tract Symptoms in Men JAMA · 2025
    2. Comparison of Finasteride and Dutasteride on Risk of Prostate Cancer in Patients with Benign Prostatic Hyperplasia: A Pooled Analysis of 15 Real-World Databases The World Journal of Men s Health · 2024
    3. Pharmacological Approaches in Managing Symptomatic Relief of Benign Prostatic Hyperplasia: A Comprehensive Review Curēus · 2023
    4. 5-Alpha Reductase Inhibitors Use in Prostatic Disease and Beyond Translational Andrology and Urology · 2023
    5. Efficacy and Safety of Finasteride Monotherapy in Patients with Benign Prostatic Hyperplasia: A Critical Review of the Literature Archivio Italiano di Urologia e Andrologia · 2020
    6. The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia The New England Journal of Medicine · 2003
    7. The Effect of Finasteride on the Expression of Vascular Endothelial Growth Factor and Microvessel Density: A Possible Mechanism for Decreased Prostatic Bleeding in Treated Patients The Journal of Urology · 2003
    8. Urinary Retention in Patients with BPH Treated with Finasteride or Placebo Over 4 Years European Urology · 2000